查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511803

RNAi 技術市場規模、佔有率、趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場進行預測，2024-2030 年

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

RNAi技術市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球RNAi技術市場規模將達到66.5億美元，2024年至2030年複合年成長率為14.6%。

預計在預測期內，技術進步以及藥物發現和藥物開發應用的增加將增加對 RNAi 技術的需求。

COVID-19 大流行對市場產生了積極影響。開發針對 COVID-19 的有效治療方法和疫苗的迫切需求導致對基於 RNA 的技術（包括 RNAi）的資金和投資激增。各國政府、製藥公司和生技公司在RNA研究上投入大量資金，加速了RNAi療法的開發和商業化。因此，在預測期內對 RNAi 技術的需求正在增加。

此外，政府對醫療保健的投資增加預計將在預測期內推動市場成長。各國政府和相關組織正在努力透過推廣生物製藥治療來最大限度地減少感染疾病的醫療支出。國際醫療保健組織正在幫助提高意識並發現各種疾病的新治療方法。增加用於臨床研究的外部資金以引入新的藥物治療對於產品開發至關重要。政府主導正在推動市場擴張。

然而，低度開發國家嚴重缺乏熟練的專業人員和研究支持，這對其進入動態市場的能力產生了重大影響。教育差距和持續培訓機會的缺乏加劇了訓練有素的勞動力的缺乏。同時，有限的研究經費、基礎設施不足和監管複雜性阻礙了這些地區的科學進步。預計這將阻礙預測期內的市場成長。

RNAi 技術市場報告亮點

  • 2023年的產品和服務市場中，產品部門佔收益佔有率最高。產品細分又分為miRNA、siRNA等。這是由於產品的高滲透率和套件和試劑的高使用率。同時，服務業預計將在預測期內以最快的速度成長。
  • 按應用來看，藥物發現和藥物開發領域預計將在2023年佔據最大的市場佔有率，達到68.87%，並在預測期內以最快的速度成長。這是由於對新藥的需求不斷增加和技術進步不斷擴大。
  • 根據最終用途，製藥和生物技術公司在該領域佔據主導地位，2023 年收益佔有率最高，達到 56.54%。另一方面，CRO&CMO 預計在預測期內將以最快的複合年成長率成長。
  • 由於強大的醫療基礎設施、先進醫療技術的高採用率以及對生物製藥研發的大量投資，北美地區在 2023 年將佔據 38.54% 的市場佔有率。同時，亞太地區預計在預測期內將以最高的複合年成長率成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第 4 章 RNAi 技術市場：產品與服務的商業分析

  • 產品和服務細分儀表板
  • 全球RNAi技術市場產品與服務波動分析
  • 2018-2030年全球RNAi技術市場規模與趨勢分析（依產品與服務）
  • 產品
  • 服務

第5章RNAi技術市場：應用商業分析

  • 使用細分儀表板
  • 全球RNAi技術市場應用與波動分析
  • 2018-2030年全球RNAi技術市場規模及趨勢分析（依應用）
  • 藥物發現與開發
  • 功能基因體學
  • 其他

第6章 RNAi 技術市場：最終用途業務分析

  • 最終用途細分儀表板
  • 全球RNAi技術市場的最終用途變化分析
  • 2018-2030 年全球 RNAi 技術市場規模與趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 學術研究所
  • 合約研究官（CRO）和首席行銷長（CMO）

第 7 章 RNAi 技術市場：按產品/服務、應用和最終用途進行區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測及趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 參與企業
  • 策略規劃
  • 2023 年企業市場分析
  • 參與企業概況
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Creative Biolabs
    • GenScript
    • Revvity
    • Promega Corporation
    • OriGene Technologies, Inc.
    • Altogen Biosystems
    • Danaher
    • Bioneer Corporation

第9章 分析師觀點

Product Code: GVR-4-68040-295-6

RNAi Technology Market Growth & Trends:

The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing technological advancements and increasing applications in drug discovery and development are anticipated to increase the demand for RNAi technology over the forecast period.

The COVID-19 pandemic has had a positive impact on the market. The urgency to develop effective treatments and vaccines for COVID-19 led to a surge in funding and investments in RNA-based technologies, including RNAi. Governments, pharmaceutical companies, and biotech firms invested heavily in RNA research, accelerating the development and commercialization of RNAi therapies. This has increased the demand for RNAi technologies during the forecast period.

Moreover, growing government investments in healthcare are anticipated to fuel market growth over the forecast period. The government and relevant bodies are taking efforts to minimize healthcare expenditure on infectious diseases by promoting biopharmaceutical treatments. International healthcare institutions contribute to raising awareness and the discovery of new therapies for various disorders. Increasing external funding for clinical studies to introduce new drug treatments is pivotal for product development. Government-led initiatives to expedite the development of drug delivery platforms for reducing disease burden are driving market expansion.

However, undeveloped countries have a substantial shortage of skilled professionals and research support, profoundly impacting their participation in the dynamic market. The scarcity of a well-trained workforce is exacerbated by educational disparities and a lack of continuous training opportunities. Simultaneously, limited research funding, infrastructure shortcomings, and regulatory complexities impede scientific progress in these regions. This is anticipated to hamper the market's growth over the forecast period.

RNAi Technology Market Report Highlights:

  • The products segment dominated the product & services market with the highest revenue share in 2023. The product segment is further segmented into miRNA, siRNA, and others. This is attributed to the high product penetration and high usage of kits & reagents. On the other hand, services are expected to grow at the fastest rate over the forecast period
  • The drug discovery & development segment held the largest market share of 68.87% in 2023 for the application segment and is anticipated to grow at the fastest rate over the forecast period. This is attributed to the increasing demand for new drugs and growing technological advancements
  • Based on end-use, pharmaceutical & biotechnology companies dominated the segment with the largest revenue share of 56.54% in 2023. On the other hand, CROs & CMOs are anticipated to grow at the fastest CAGR over the forecast period
  • The North American region dominated the market share of 38.54% in 2023 due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Region
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing applications of RNAi technology in research and medicine
      • 3.2.1.2. Growing interest in personalized medicine
      • 3.2.1.3. Technological advancements in RNAi techniques
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professionals and research support in developing countries
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. RNAi Technology Market: Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global RNAi Technology Market Product & Service Movement Analysis
  • 4.3. Global RNAi Technology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Global Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. miRNA
      • 4.4.2.1. Global miRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. siRNA
      • 4.4.3.1. Global siRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. RNAi Technology Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global RNAi Technology Market Application, Movement Analysis
  • 5.3. Global RNAi Technology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Drug Discovery & Development
    • 5.4.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Neurology
      • 5.4.2.1. Global Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Oncology
      • 5.4.3.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Infectious Diseases
      • 5.4.4.1. Global Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Metabolic Diseases
      • 5.4.5.1. Global Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Functional Genomics
    • 5.5.1. Global Functional Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. RNAi Technology Market: End-use Business Analysis

  • 6.1. End-use Segment Dashboard
  • 6.2. Global RNAi Technology Market End-use Movement Analysis
  • 6.3. Global RNAi Technology Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. CROs & CMOs
    • 6.6.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Participant's Overview
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Creative Biolabs
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Revvity
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. OriGene Technologies, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Altogen Biosystems
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Danaher
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Bioneer Corporation
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

Chapter 9. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 Global RNAi technology market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 12 U.S. RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Canada RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 15 Canada RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Mexico RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 18 Mexico RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 22 Europe RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 25 UK RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 28 Germany RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 France RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 31 France RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 32 France RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Italy RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 Italy RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 37 Spain RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Denmark RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 40 Denmark RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 41 Denmark RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 43 Sweden RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Sweden RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Norway RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Norway RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 47 Norway RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Japan RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 53 Japan RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 China RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 56 China RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 57 China RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 India RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 59 India RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 60 India RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Australia RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Australia RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 65 Thailand RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 66 Thailand RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 South Korea RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 68 South Korea RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 69 South Korea RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Latin America RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Latin America RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 73 Latin America RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Brazil RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 Brazil RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 76 Brazil RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 78 Argentina RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 85 South Africa RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 UAE RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 91 UAE RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 94 Kuwait RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 RNAi technology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 RNAi technology market driver analysis
  • Fig. 12 RNAi technology market restraint analysis
  • Fig. 13 RNAi technology market: Porter's analysis
  • Fig. 14 RNAi technology market: PESTEL analysis
  • Fig. 15 RNAi technology market: Product & service outlook and key takeaways
  • Fig. 16 RNAi technology market: Product & service market share analysis, 2023 - 2030
  • Fig. 17 Global RNAi technology by products market, 2018 - 2030 (USD Million)
  • Fig. 18 Global RNAi technology by miRNA market, 2018 - 2030 (USD Million)
  • Fig. 19 Global RNAi technology by siRNA market, 2018 - 2030 (USD Million)
  • Fig. 20 Global RNAi technology by others market, 2018 - 2030 (USD Million)
  • Fig. 21 Global RNAi technology by service market, 2018 - 2030 (USD Million)
  • Fig. 22 RNAi technology market: Application outlook and key takeaways
  • Fig. 23 RNAi technology market: Application market share analysis, 2023 - 2030
  • Fig. 24 Global RNAi technology by drug discovery & dvelopment market, 2018 - 2030 (USD Million)
  • Fig. 25 Global RNAi technology by neurology market, 2018 - 2030 (USD Million)
  • Fig. 26 Global RNAi technology by oncology market, 2018 - 2030 (USD Million)
  • Fig. 27 Global RNAi technology by infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 28 Global RNAi technology by metabolic diseases market, 2018 - 2030 (USD Million)
  • Fig. 29 Global RNAi technology by others market, 2018 - 2030 (USD Million)
  • Fig. 30 Global RNAi technology by functional genomics market, 2018 - 2030 (USD Million)
  • Fig. 31 Global RNAi technology others market, 2018 - 2030 (USD Million)
  • Fig. 32 RNAi technology market: End-use outlook and key takeaways
  • Fig. 33 RNAi technology market: End-use market share analysis, 2023 - 2030
  • Fig. 34 Global RNAi technology by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 35 Global RNAi technology by academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 36 Global RNAi technology by CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada RNAi technology market, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 UK RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 France RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Spain RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Norway RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Japan RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 China RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 India RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Australia RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 MEA RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UAE RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key company categorization
  • Fig. 67 Company market positioning
  • Fig. 68 Market participant categorization
  • Fig. 69 Strategy framework